What is iRespond?
Founded in 2010, iRespond is dedicated to improving the quality of care and lives worldwide by leveraging advanced technologies and global communications. The organization's core offering is the IRIS software application platform, a secure, encrypted health-care data collection system that utilizes specialized biometric technologies. This platform is particularly vital for providing secure patient databases and seamless record access in isolated locations, far from major medical facilities. iRespond fosters a collaborative network, enabling global government and non-government organizations to safely exchange information via secure, local cloud-based servers, thereby increasing availability, reach, and operational efficiency. The company actively builds essential partnerships with support organizations, government agencies, foundations, and local community groups, alongside unique agreements with the private sector, to ensure its technologies and strategies are deployed effectively where needed.
How much funding has iRespond raised?
iRespond has raised a total of $70K across 1 funding round:
Debt
$70K
Debt (2021): $70K with participation from PPP
Key Investors in iRespond
PPP
Public-Private Partnership
What's next for iRespond?
With its recent substantial expansion capital, iRespond is poised to further scale its operations and technological development. The company's strategic focus on secure health-care data collection and global accessibility, particularly in underserved regions, aligns with a critical need for robust health infrastructure. Future investments are likely to target enhancing the IRIS platform's capabilities, expanding its reach into new geographical areas, and strengthening its network of partnerships. This continued investment underscores iRespond's commitment to its mission and its potential to make a lasting impact on global health equity.
See full iRespond company page
